Understanding Voluntary Disclosures in FDA and Customs

Understanding Voluntary Disclosures in FDA and Customs

Episode Summary: In this episode, Attorney Benjamin England sheds light on the nuances of voluntary disclosures in FDA and Customs enforcement. He explains the differences between mandatory disclosures in FDA for safety-related issues and the need for prior disclosures in Customs for duty-related matters. The discussion covers scenarios where voluntary disclosures can mitigate risks and instances where they could potentially lead to increased exposure. Key Timestamps: 00:00 – Introduction: Voluntary Disclosures in FDA and Customs Compliance 00:40 – Key Differences: FDA vs. Customs Disclosure 01:30 – FDA: Importers' Obligation to Report Safety Issues 03:00 – Compliance Responsibility: Importers vs. Manufacturers 04:30 – Increased Compliance for Direct-to-Consumer Imports 05:00 – No Formal Voluntary Disclosure System at FDA 06:00 – Customs: Prior Disclosure for Duty-Related Errors 07:30 – Proactive Reporting Reduces Penalties and Risk 09:00 – Strategic Disclosure Decisions in FDA Cases 10:00 – Customs Disclosure Limits Financial Penalties vs. Duties 11:30 – IRS Analogy: Comparing Customs to Tax Audits 12:30 – When Disclosure May Not Be Necessary 13:30 – Resolving Import Alerts and FDA Detentions 15:00 – High-Risk Customs Issues: Duties and FTAs 16:30 – Customs Investigations: Up to Seven Years of Exposure 17:30 – Factors in Disclosure Decisions: Risk, Exposure, History 18:30 – Global Variations in Compliance Risk Tolerance 19:20 – Conclusion and Key Takeaways About the Show: *FDA Imports: Cross-Border compliance with Attorney Benjamin L. England* is a podcast series hosted by Attorney Benjamin England, focusing on cross-border compliance issues in FDA and Customs regulations. The show provides expert insights and guidance for companies navigating the complexities of international trade and regulatory oversight.

Customs Post-Entry Audits Explained: CF-28s, CF-29s, and What Happens After Clearance

Episode Summary: In this episode of FDA Imports: Cross-Border Compliance, host Sean O'Connor and attorney Benjamin L. England delve into the complexities of customs post-entry audits, focusing on CF-28s and CF-29s. Benjamin, founder of FDAImports.com and a former FDA regulatory counsel, explains why importers shouldn't assume their responsibilities end once a shipment clears customs. He highlights the importance of understanding the conditional nature of customs releases and the potential for audits years after entry. The discussion covers the differences between CF-28 and CF-29 forms, the types of issues that can trigger audits, and the implications of failing to comply with customs regulations. Benjamin also offers practical advice on maintaining proper documentation and the significance of a well-drafted purchase order to mitigate risks. This episode is essential for importers looking to navigate the intricate landscape of FDA and customs compliance effectively. Key Timestamps: 00:01 – Introduction 00:07 – Overview of Customs Post-Entry Audits 00:53 – Conditional Release of Goods by Customs 01:58 – Role of FDA in Customs Compliance 03:08 – Customs Examination and Duty Calculation 04:41 – Understanding CF-28 Forms and Compliance 05:48 – Differences Between CF-28 and CF-29 07:42 – Triggers for Post-Entry Audits 10:26 – Record Keeping and Statute of Limitations 12:23 – Importance of Accurate Declarations 14:04 – FDA Involvement in Customs Investigations 16:08 – Systems to Reduce Post-Entry Audit Risks About the Show: FDA Imports: Cross-Border Compliance is a podcast designed for businesses navigating the complex world of FDA regulations and international trade. Hosted by industry experts, the show provides insights into compliance strategies, regulatory updates, and best practices for managing cross-border transactions. With a focus on clarity and practical advice, each episode aims to equip listeners with the knowledge they need to successfully import and export goods while adhering to legal requirements. Whether you're a seasoned importer or new to the field, this podcast offers valuable guidance to help you stay compliant and avoid costly pitfalls.

First FDA-Regulated Import? The Mistakes That Get Shipments Stopped

Episode Summary: In this episode of FDA Imports: Cross-Border Compliance, host Sean O'Connor is joined by Attorney Benjamin England, founder of FDAImports.com and a former FDA regulatory counsel. They delve into the complexities of first-time FDA-regulated imports, highlighting common mistakes that lead to shipment delays, detentions, or refusals. Benjamin emphasizes the importance of understanding FDA requirements from the outset, including proper documentation and compliance checks before goods leave the foreign supplier. They discuss assumptions that new importers make about FDA requirements, the role of timing in import processes, and the impact of labeling and registration details on shipments. The episode provides valuable insights for businesses entering the US market, offering practical strategies to avoid common pitfalls and ensure smooth import operations. Key Timestamps: 00:00 – Introduction 00:26 – Common Mistakes in First-Time Imports 01:12 – Importance of Early Transaction Compliance 02:39 – Assumptions About FDA Requirements 03:47 – Challenges with Proprietary Information 05:03 – Role of Customs Brokers 06:01 – FDA's Authority at the Border 07:07 – Labeling and Product Compliance Issues 08:15 – Differing FDA Expectations by Product Type 10:18 – Timing and Its Impact on Imports 12:33 – Perishable Goods and Timing Challenges 14:17 – Case Study: Dietary Supplements 17:08 – Cosmetic Products with Drug Claims 19:18 – Impact of Initial Non-Compliance on Future Imports About the Show: FDA Imports: Cross-Border Compliance is a podcast dedicated to helping businesses navigate the intricate world of FDA regulations and international trade. Hosted by industry experts, the show provides insightful discussions on compliance strategies, regulatory updates, and best practices for importing FDA-regulated products. Whether you're a seasoned importer or new to the field, this podcast offers valuable knowledge to ensure your business meets regulatory standards and avoids common pitfalls. With a focus on clarity and practical advice, FDA Imports is your go-to resource for staying informed and compliant in the ever-evolving landscape of cross-border trade.

TrumpRx.gov Explained: Why FDA and Customs Are Cracking Down on Drug Imports

Episode Summary: In this episode of *FDA Imports: Cross-Border Compliance* Benjamin England delves into the significance of TrumpRX.gov in the context of drug pricing policy and pharmaceutical importation. Exploring the complexities of pharmaceutical pricing disparities between the US and Europe, Ben sheds light on the regulatory changes initiated by the Trump administration to facilitate the importation of pharmaceuticals, offering a potential solution to high drug costs for American consumers. Key Timestamps: 00:00 – Introduction 02:30 – TrumpRX.gov: A Game-Changer in Pharmaceutical Pricing 06:45 – The Implications of Temporary Programs on Industry Players 10:15 – Enforcement Approaches to Gray Market Rx Drugs 14:50 – Mitigating Risks in Pharmaceutical Importation 18:25 – The Complexities of Regulatory Scrutiny and Sourcing Patterns About the Show: *FDA Imports: Cross-Border Compliance* provides expert insights into cross-border compliance issues related to FDA regulations and international trade. Led by Attorney Benjamin England, the show navigates the intricate landscape of FDA oversight, regulatory compliance, and importation challenges faced by businesses worldwide.

FDA’s ‘No Artificial Colors’ Shift: When Enforcement Changes but the Law Doesn’t

Episode Summary: In this episode of FDA Imports: Cross Border Compliance with Attorney Benjamin England sheds light on the FDA's recent enforcement discretion around color additives, impacting labeling regulations and creating confusion for importers. He clarifies the distinction between natural and synthetic colors, discusses the FDA's changing approach to artificial colors claims, and outlines the compliance challenges importers may face in light of this guidance. Key Timestamps: 00:00 – Introduction 02:15 – Differentiating between natural and synthetic colors 04:30 – FDA's enforcement discretion on artificial colors claims 07:45 – Compliance implications for importers 11:20 – Potential risks and considerations for companies 15:00 – Navigating FDA's evolving enforcement expectations About the Show: *FDA Imports: Cross Border Compliance with Attorney Benjamin England* is the go-to podcast for insights into cross-border compliance issues, hosted by industry expert Benjamin England. Join as the show unravel the complexities of FDA regulations and provide valuable guidance for businesses dealing with import compliance challenges.